Skip to content
GenoLensGenoLens

PDE6B

Chr 4p16.3

phosphodiesterase 6B

Aliases:
CSNB3, rd1, RP40, CSNBAD2
MANE:
ENST00000496514.6

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Retinal disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Glaucoma (developmental)

  • Structural eye disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • retinitis pigmentosa

    0.82
  • congenital stationary night blindness

    0.70
  • Retinal dystrophy

    0.58
  • coronary artery disorder

    0.54
  • stroke disorder

    0.53
  • autosomal recessive retinitis pigmentosa

    0.49
  • cardiovascular disorder

    0.43
  • intermittent vascular claudication

    0.43
  • Posterior column ataxia - retinitis pigmentosa

    0.38
  • inherited retinal dystrophy

    0.38

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta

Catalytic beta subunit of the rod-specific cGMP phosphodiesterase (PDE6) complex, which hydrolyzes 3',5'-cyclic GMP in the phototransduction cascade. The PDE6 holoenzyme consists of two catalytic subunits (PDE6A and PDE6B) and two inhibitory gamma subunits (PDE6G) (PubMed:20940301). Light-activated GNAT1 relieves gamma subunit-mediated inhibition, enabling the catalytic subunits to hydrolyze cGMP and thereby mediate visual signal transduction and amplification (PubMed:8394174). Decreased cytosolic cGMP levels result in closure of cGMP-gated cation channels at the plasma membrane, leading to rod photoreceptor hyperpolarization (Probable). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity)

Curated MONDO disease pages that list PDE6B among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.